| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 387 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 382 |
| 2 | TACROLIMUS OINTMENT 0.1% | 382 |
| 3 | CYCLOSPORINE | 367 |
| 4 | METHOTREXATE SODIUM | 357 |
| 5 | FLUDARABINE PHOSPHATE | 346 |
| 6 | METHOTREXATE | 337 |
| 7 | RITUXIMAB | 308 |
| 8 | CYCLOPHOSPHAMIDE | 305 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 305 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 44 | 0.0304 |
| 1 | TREOSULFAN | 52 | 0.0188 |
| 2 | SILTUXIMAB | 9 | 0.0139 |
| 3 | BUSULFAN | 199 | 0.0125 |
| 4 | TEPLIZUMAB-MZWV | 8 | 0.0111 |
| 5 | CLOFARABINE | 24 | 0.0105 |
| 6 | FOSCARNET SODIUM | 40 | 0.0099 |
| 7 | FLUDARABINE PHOSPHATE | 346 | 0.0087 |
| 8 | THIOTEPA | 77 | 0.0079 |
| 9 | LETERMOVIR | 22 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 570 |
| 1 | Alkylating Drug [EPC] | 423 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 367 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 337 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 316 |
| 5 | Kinase Inhibitor [EPC] | 210 |
| 6 | Janus Kinase Inhibitor [EPC] | 137 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 129 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 127 |
| 9 | Topoisomerase Inhibitor [EPC] | 116 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 9 | 0.0139 |
| 1 | CD3-directed Antibody [EPC] | 8 | 0.0111 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 22 | 0.0068 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 129 | 0.0067 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 25 | 0.0043 |
| 5 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 91 | 0.0041 |
| 7 | CD123 Interaction [EPC] | 2 | 0.0037 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 12 | 0.0028 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 367 | 0.0028 |